These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


189 related items for PubMed ID: 8611437

  • 1. Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma. The International SL-DOX Study Group.
    Goebel FD, Goldstein D, Goos M, Jablonowski H, Stewart JS.
    Br J Cancer; 1996 Apr; 73(8):989-94. PubMed ID: 8611437
    [Abstract] [Full Text] [Related]

  • 2. Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma.
    Coukell AJ, Spencer CM.
    Drugs; 1997 Mar; 53(3):520-38. PubMed ID: 9074848
    [Abstract] [Full Text] [Related]

  • 3. A phase II study of liposomal doxorubicin in the treatment of HIV-related Kaposi's sarcoma.
    Newell M, Milliken S, Goldstein D, Lewis C, Boyle M, Dolan G, Ryan S, Cooper DA.
    Aust N Z J Med; 1998 Dec; 28(6):777-83. PubMed ID: 9972406
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy.
    Northfelt DW, Dezube BJ, Thommes JA, Levine R, Von Roenn JH, Dosik GM, Rios A, Krown SE, DuMond C, Mamelok RD.
    J Clin Oncol; 1997 Feb; 15(2):653-9. PubMed ID: 9053490
    [Abstract] [Full Text] [Related]

  • 5. Liposomal doxorubicin in pulmonary Kaposi's sarcoma: improved survival as compared to patients without liposomal doxorubicin.
    Grünaug M, Bogner JR, Loch O, Goebel FD.
    Eur J Med Res; 1998 Feb 21; 3(1-2):13-9. PubMed ID: 9512962
    [Abstract] [Full Text] [Related]

  • 6. Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy.
    Gordon KB, Tajuddin A, Guitart J, Kuzel TM, Eramo LR, VonRoenn J.
    Cancer; 1995 Apr 15; 75(8):2169-73. PubMed ID: 7697608
    [Abstract] [Full Text] [Related]

  • 7. Long-term chemotherapy of HIV-associated Kaposi's sarcoma with liposomal doxorubicin.
    Hengge UR, Esser S, Rudel HP, Goos M.
    Eur J Cancer; 2001 May 15; 37(7):878-83. PubMed ID: 11313176
    [Abstract] [Full Text] [Related]

  • 8. Population pharmacokinetics and pharmacodynamics of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma.
    Amantea MA, Forrest A, Northfelt DW, Mamelok R.
    Clin Pharmacol Ther; 1997 Mar 15; 61(3):301-11. PubMed ID: 9084455
    [Abstract] [Full Text] [Related]

  • 9. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.
    Northfelt DW, Dezube BJ, Thommes JA, Miller BJ, Fischl MA, Friedman-Kien A, Kaplan LD, Du Mond C, Mamelok RD, Henry DH.
    J Clin Oncol; 1998 Jul 15; 16(7):2445-51. PubMed ID: 9667262
    [Abstract] [Full Text] [Related]

  • 10. Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma.
    Harrison M, Tomlinson D, Stewart S.
    J Clin Oncol; 1995 Apr 15; 13(4):914-20. PubMed ID: 7707119
    [Abstract] [Full Text] [Related]

  • 11. Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma.
    Northfelt DW, Martin FJ, Working P, Volberding PA, Russell J, Newman M, Amantea MA, Kaplan LD.
    J Clin Pharmacol; 1996 Jan 15; 36(1):55-63. PubMed ID: 8932544
    [Abstract] [Full Text] [Related]

  • 12. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.
    Gill PS, Wernz J, Scadden DT, Cohen P, Mukwaya GM, von Roenn JH, Jacobs M, Kempin S, Silverberg I, Gonzales G, Rarick MU, Myers AM, Shepherd F, Sawka C, Pike MC, Ross ME.
    J Clin Oncol; 1996 Aug 15; 14(8):2353-64. PubMed ID: 8708728
    [Abstract] [Full Text] [Related]

  • 13. Liposomal doxorubicin for treatment of AIDS-related Kaposi's sarcoma.
    Simpson JK, Miller RF, Spittle MF.
    Clin Oncol (R Coll Radiol); 1993 Aug 15; 5(6):372-4. PubMed ID: 8305358
    [Abstract] [Full Text] [Related]

  • 14. A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma.
    Cooley T, Henry D, Tonda M, Sun S, O'Connell M, Rackoff W.
    Oncologist; 2007 Jan 15; 12(1):114-23. PubMed ID: 17227906
    [Abstract] [Full Text] [Related]

  • 15. The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin.
    Berry G, Billingham M, Alderman E, Richardson P, Torti F, Lum B, Patek A, Martin FJ.
    Ann Oncol; 1998 Jul 15; 9(7):711-6. PubMed ID: 9739435
    [Abstract] [Full Text] [Related]

  • 16. Liposomal doxorubicin (Doxil): an effective new treatment for Kaposi's sarcoma in AIDS.
    James ND, Coker RJ, Tomlinson D, Harris JR, Gompels M, Pinching AJ, Stewart JS.
    Clin Oncol (R Coll Radiol); 1994 Jul 15; 6(5):294-6. PubMed ID: 7530036
    [Abstract] [Full Text] [Related]

  • 17. Liposomal doxorubicin in AIDS-related Kaposi's sarcoma: long-term experiences.
    Wagner D, Kern WV, Kern P.
    Clin Investig; 1994 Jun 15; 72(6):417-23. PubMed ID: 7950152
    [Abstract] [Full Text] [Related]

  • 18. Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group.
    Stewart S, Jablonowski H, Goebel FD, Arasteh K, Spittle M, Rios A, Aboulafia D, Galleshaw J, Dezube BJ.
    J Clin Oncol; 1998 Feb 15; 16(2):683-91. PubMed ID: 9469358
    [Abstract] [Full Text] [Related]

  • 19. Liposomal doxorubicin: new preparation. Useful in Kaposi's sarcoma.
    Prescrire Int; 1998 Jun 15; 7(35):69-70. PubMed ID: 10342919
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.